News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Cardinal Health Announces Resignation of Director; Declares Regular Quarterly Dividend
01/31/2008
Matthew D. Walter resigns from the board of directors, 94th consecutive regular quarterly dividend declared

DUBLIN, Ohio, Jan. 31, 2008 — Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced the resignation of Matthew D. Walter from the board of directors and declared its 94th consecutive regular quarterly dividend.

 

 

“We want to thank Matt for his outstanding service as a director of Cardinal Health,” said John B. McCoy, chairman of the Nominating and Governance Committee. “During his six years on the board, Cardinal Health doubled in size and made significant expansions into medical technologies and with international operations.  We thank him for his service and wish him well as he continues to focus on his professional objectives and business interests.”

 

Walter, 39, is chairman and chief executive officer of BoundTree Medical Products and has been a director since 2002. The company will not fill Walter’s board seat and will reduce the size of the board to 14 directors.

 

The board of directors also approved a regular quarterly dividend of $0.12 per share, payable on April 15, 2008 to shareholders of record on April 1, 2008. The company had approximately 357 million shares outstanding as of Jan. 25. 

 

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $87 billion, global company serving the health-care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients.  With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris® IV pumps, Pyxis® automated dispensing systems, MedMined™ electronic infection surveillance service, VIASYS® respiratory care products and the CareFusion™ patient identification system.  The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide.  Ranked No. 19 on the Fortune 500 and No. 1 in its sector on Fortune's ranking of Most Admired firms, Cardinal Health employs more than 40,000 people on five continents.  More information about the company may be found at www.cardinalhealth.com.

More Company News
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

04/07/2021

By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health

04/07/2021

Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...

03/30/2021

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields